Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Methotrexate Supported by Glucarpidase in PCNSL
NCT00727831Phase 2Completed
- Sponsor
- University College London
- Start
- Jul 2008
- Primary completion
- Jul 2011
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of glucarpidase in primary central nervous system lymphoma (PCNSL), sponsored by University College London. Started Jul 2008; status: completed.
02
Drugs
glucarpidase
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT00727831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00727831.